Evidence map›Paper›PMID 15557797›Full record

ArticleJournal of mammary gland biology and neoplasia2004

BRCA1 and BRCA2 in breast cancer predisposition and recombination control.

Ralph Scully, Anyong Xie

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of mammary gland biology and neoplasia, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ralph ScullyBeth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.
Anyong Xie

Funding

ANALYSIS OF BRCA1 RECOMBINATION FUNCTIONSR01CA095175 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2002 to 2021
$4.9M
FUNCTIONAL ANALYSIS OF BRCA1K01CA079576 · NCI · DANA-FARBER CANCER INSTITUTE · PI SCULLY, RALPH · 1999 to 2003
$611k
NCI NIH HHS K01CA79576NCI NIH HHS R01 CA095175NCI NIH HHS R01CA95175
6 · The paper itself

Abstract

Hereditary predisposition to breast and ovarian cancer is determined in large part by loss-of-function mutations in one of two genes, BRCA1 and BRCA2 . Early discoveries that the two genes function in the control of homologous recombination and the prevention of genomic instability have been strongly supported by subsequent work. Our aim here is to highlight new advances in the study of BRCA1 and BRCA2 , and to place these advances in the context of existing knowledge.

Indexed as

Genes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseRecombination, GeneticBreast NeoplasmsDNAFemaleHumansMutationOvarian NeoplasmsDNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.